These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 20937181

  • 1. Risk of relapse and failure after retreatment with the Category II regimen in Nepal.
    Yoshiyama T, Shrestha B, Maharjan B.
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1418-23. PubMed ID: 20937181
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC.
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antitubercular chemotherapy].
    Jouveshomme S, Dautzenberg B.
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR, Agarwal SK, Shah KV.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [Abstract] [Full Text] [Related]

  • 12. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L, Zheng SH, Chu NH, Xie YG, Yang YZ, Li Q, Wang XM, Yan XL, Tan WG, Miao ZP, Duanmu HJ.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3387-91. PubMed ID: 19159566
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
    Kenyon TA, Mwasekaga MJ, Huebner R, Rumisha D, Binkin N, Maganu E.
    Int J Tuberc Lung Dis; 1999 Jan 30; 3(1):4-11. PubMed ID: 10094163
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.